FFOX
FundX Future Fund Opportunities ETF
FundX Future Fund Opportunities ETF seeks to provide long-term capital appreciation by investing in a diversified portfolio of equity securities, including those of emerging companies and sectors poised for growth.
US
EQUITY
Active
MANAGEMENT STYLE
$ 199.4 M
ASSETS UNDER MGMT
100 bp
EXPENSES
Fund Basics
| Inception date | Jun 09, 2025 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | Yes |
Top 10 Holdings
Complete list +
| CASH & OTHER | 4.5 % |
| TECHNIPFMC PLC | 3.3 % |
| MILLICOM INTL CELLULAR S.A. | 3.1 % |
| GLOBUS MEDICAL INC - A | 2.2 % |
| IONIS PHARMACEUTICALS, INC. | 2.1 % |
| BWX TECHNOLOGIES, INC. | 2.0 % |
| GUARDANT HEALTH, INC. | 2.0 % |
| HALOZYME THERAPEUTICS INC | 1.9 % |
| ADVANCED DRAINAGE SYSTEMS INC | 1.8 % |
| FIRSTCASH, INC. | 1.8 % |
Constituent Breakdown
| Number of holdings | 73 |
| Herfindahl-Hirschman Index | 10 |
| Wgt avg mkt cap (mns) | $0 |
| Large cap (>$10bn) | 0.0% |
| Mid cap ($2-10bn) | 0.0% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 91.1% |
| Emerging mkts. | 2.9% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 80.2 % |
 |
BRITAIN | 3.3 % |
 |
LUXEMBOURG | 3.1 % |
 |
CHINA | 1.5 % |
 |
CAYMAN ISLANDS | 1.5 % |
 |
BRAZIL | 1.1 % |
Historical Performance
Standardized Performance (as of 02/28/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 5.5% | -- | -- | -- | -- | -- | -- | 14.0% |
| Dividend Yield | 0.0% | -- | -- | -- | -- | -- | -- | 0.0% |
| Total Returns | 5.5% | -- | -- | -- | -- | -- | -- | 14.0% | Ann. Volatility | 18.1% | -- | -- | -- | -- | -- | -- | 15.9% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.00 | 0% |
| MSCI EAFE | 0.00 | 0% |
| MSCI Emg Mkts | 0.00 | 0% |
Liquidity Measures
| Avg. volume (000) | 28 |
| ADV traded (mns) | $1 |
| Turnover | 0.4% |
| Avg. Bid/Ask (% of price) | 0.15% |
Technical Indicators
| 30d moving avg. (EMA) | $27.47 |
| Relative strength (RSI) | 39 |
| MACD/Signal | -0.51/-0.42 |
| Bollinger Bands (Upper/Lower) | $28.81/$25.79 |
| Short interest (% of AUM) | 0.2% |
Distributions
Assets Under Management (mns)
Money Flows (mns)
Short Interest (as % of shares outstanding)
Long Money Flows (mns)
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. FFOX |
Expenses vs. FFOX |
ALTAR Score™ vs. FFOX |
|---|---|---|---|---|
| MMSC | First Trust Multi-Manager Small Cap Opportunities ETF | 16.5% | -5 bp | -3.6% |
| DBSC | Deepwater Beachfront Small Cap ETF | 16.0% | -15 bp | -1.2% |
| RSMC | Rockefeller U.S. Small-Mid Cap ETF | 15.8% | -25 bp | +1.6% |
| XSMO | Invesco S&P SmallCap Momentum ETF | 15.2% | -61 bp | +1.0% |
| RFG | Invesco S&P Midcap 400 Pure Growth ETF | 13.2% | -65 bp | +2.2% |
| MDYG | State Street SPDR S&P 400 Mid Cap Growth ETF | 12.5% | -85 bp | +1.4% |
| IJK | iShares S&P Mid-Cap 400 Growth ETF | 12.5% | -83 bp | +1.4% |
| RNSC | Furst Trust Small Cap US Equity Select ETF | 12.5% | -40 bp | +2.1% |
| IVOG | Vanguard S&P Mid-Cap 400 Growth ETF | 12.5% | -90 bp | +1.4% |
| PAMC | Pacer Lunt MidCap Multi-Factor Alternator ETF | 12.4% | -40 bp | +4.5% |
Risk and Returns: FFOX vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/3/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
3.8%
ALTAR SCORE™
17th
PERCENTILE
AVOID
ETFRC RATING
There are 1,196 funds in the US Equity category with an average
ALTAR Score™ of 5.7% and a standard deviation
of 2.1%. FFOX's ALTAR Score™ is approximately -1.0 standard
deviations above the category average. This places FFOX in the 17th percentile
among funds in the category.
Sell-Side Consensus
$35.46
PRICE TARGET
+32.7%
UPSIDE